Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

Increased PrEP usage is linked to decreased HIV diagnosis rates, with a notable decline from 13.0 to 10.6 per 100,000 over a decade. State-level PrEP coverage significantly impacts HIV diagnosis rates ...

At the beginning of June, the Texas Department of State Health Services asked all programs funded by the CDC’s HIV Prevention ...

National HIV Testing Day, celebrated on June 27 each year, is an important annual reminder to get tested and know your status ...

The CDC recently published revised recommendations urging routine HIV screening in healthcare settings for individuals age 13 to 64, unless they opt out. This is not the first time that the CDC ...

Winnie Byanyima says her organization has lost almost 50% of its funding, a gap that is undermining global efforts to combat HIV/AIDS.

In Fiscal Year 2024 and 2025, the CDC got over one billion dollars for HIV, AIDS, and STD prevention. 2026’s budget now gives them only over a quarter of that, which is about $300 million.

JACKSON, Miss. — The FDA has approved Yeztugo, the world’s first twice-a-year shot to prevent HIV infection, marking a significant advancement in HIV prevention. The new treatment is expected to be a ...

FDA approves Yeztugo as the first U.S. twice-yearly injectable for HIV prevention, showing 99.9% efficacy and broad access for all patients.

WASHINGTON D.C., DC — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it's ...

Global efforts at ending the HIV pandemic by 2030 have stalled. There still are more than 30,000 new infections in the U.S. each year and about 1.3 million worldwide.

A June stu d y estimated as many as 2.2 million Americans could benefit from HIV prevention medications. Men account for nearly 80% of new cases, mostly involving gay or bisexual men, the CDC said.